We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
(-16%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-15.9%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
+$17.9M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$17.3M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$14M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$12.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seer Inc
SEER
|
+$24.7M |
| 2 |
MAPS
WM TECHNOLOGY INC A
MAPS
|
+$23.4M |
| 3 |
LivaNova
LIVN
|
+$20.2M |
| 4 |
Glaukos
GKOS
|
+$17.5M |
| 5 |
Cooper Companies
COO
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.75% |
| 2 | Consumer Staples | 0.58% |
| 3 | Financials | 0.5% |
| 4 | Consumer Discretionary | 0.42% |
| 5 | Industrials | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $285M | 10.32% |
600,000
+50,000
| +9% | +$23M |
|
2
PUT
Invesco QQQ Trust
QQQ
$479B
| $199M | 7.2% |
500,000
-350,000
| -41% | -$135M |
|
3
PUT
iShares S&P 100 ETF
OEF
$20.5B
| $150M | 5.44% |
675,000
+75,000
| +13% | +$15.9M |
|
|
VRAY
4
DELISTED
ViewRay, Inc.
VRAY
| $77.7M | 2.81% |
14,106,860
+2,945,772
| +26% | +$17.9M |
|
5
Establishment Labs
ESTA
$2.33B
| $76.1M | 2.76% |
1,126,198
+39,737
| +4% | +$2.78M |
|
6
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
| $59.4M | 2.15% |
+901,600
| New | +$60.6M |
|
7
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
| $56.4M | 2.04% |
400,000
+325,000
| +433% | +$43.2M |
|
8
CALL
Biogen
BIIB
$30.5B
| $54.4M | 1.97% |
226,700
+197,300
| +671% | +$50.7M |
|
|
NSTG
9
DELISTED
NanoString Technologies, Inc.
NSTG
| $50M | 1.81% |
1,183,560
-140,605
| -11% | -$6.15M |
|
10
Inspire Medical Systems
INSP
$1.7B
| $49.3M | 1.79% |
214,442
+9,932
| +5% | +$2.42M |
|
|
CUTR
11
DELISTED
Cutera, Inc.
CUTR
| $46.1M | 1.67% |
1,115,411
+310,057
| +38% | +$12.7M |
|
|
12
LivaNova
LIVN
$4.17B
| $44.1M | 1.6% |
504,767
-242,705
| -32% | -$20.2M |
|
|
13
CALL
Glaukos
GKOS
$10.1B
| $37.8M | 1.37% |
850,600
+600,600
| +240% | +$27.7M |
|
14
PUT
Abbott
ABT
$187B
| $36.6M | 1.33% |
260,000
+160,000
| +160% | +$20.5M |
|
15
PUT
Medtronic
MDT
$110B
| $33.6M | 1.22% |
+325,000
| New | +$37.6M |
|
16
PUT
ARK Innovation ETF
ARKK
$6.01B
| $33.1M | 1.2% |
350,000
-50,000
| -13% | -$5.46M |
|
17
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.19B
| $31.3M | 1.14% |
280,000
-45,000
| -14% | -$7.47M |
|
18
PUT
ARK Genomic Revolution ETF
ARKG
$1.63B
| $30.6M | 1.11% |
500,000
-150,000
| -23% | -$10.4M |
|
19
PUT
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$273M
| $30.6M | 1.11% |
246,400
-53,600
| -18% | -$3.31M |
|
20
PUT
Stryker
SYK
$129B
| $29.4M | 1.07% |
+110,000
| New | +$28.9M |
|
|
SLGC
21
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $28.9M | 1.05% |
2,485,415
+1,447,770
| +140% | +$17.3M |
|
22
ICU Medical
ICUI
$4.16B
| $28.5M | 1.03% |
119,976
-14,748
| -11% | -$3.44M |
|
|
ARNA
23
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $27.1M | 0.98% |
291,100
-8,900
| -3% | -$586K |
|
|
IMDX
24
Insight Molecular Diagnostics
IMDX
$155M
| $26.5M | 0.96% |
611,198
| – | – |
|
25
PUT
10x Genomics
TXG
$5.79B
| $26.4M | 0.96% |
177,400
+17,400
| +11% | +$2.67M |
|
Similar funds
BCA
ONGA
RC
DOFI
SR
SCI
LPC
GBCP
Pura Vida Investments's Q4 2021 Portfolio in Review
As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.
- Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
- Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
- Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
- Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
- Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
- Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
- Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.
Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.